1 AB098 Can concomitant dutasteride reduce the effect of testosterone replacement therapy in men with late-onset hypogonadism? A 24-week, randomized, parallel study
luellachan6351 edited this page 2026-04-02 22:41:19 +08:00
This file contains ambiguous Unicode characters

This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.



Finasteride results in a decrease of circulating DHT levels by about 6570% with an oral dosage of 5 mg/day and of DHT levels in the prostate gland by up to 8090% with an oral dosage of 1 or 5 mg/day. While finasteride—marketed by Organon as Propecia—already includes warnings about possible psychiatric effects, the EMA stated that the evidence did not support a similar link for dutasteride, sold by GSK under the brand name Avodart. The majority of these reports involved patients taking the 1 mg dosage, typically prescribed for androgenetic alopecia, a hormone-related form of hair loss. The adverse effect profiles of finasteride are somewhat different for its indications of hair loss and BPH.citation needed Sexual adverse effects of finasteride and dutasteride have been linked to lower quality of life and ability to maintain an intimate relationship, [git.beyondtheuniverse.superviber.com](https://git.beyondtheuniverse.superviber.com/ilenegartrell8) and can cause stress in relationships. Merck's patent on finasteride for the treatment of BPH expired in June 2006. Finasteride is marketed primarily under the brand names Propecia, for pattern hair loss, and Proscar, for BPH, both of which are products of Merck & Co. It was the first 5α-reductase inhibitor to be introduced and was followed by dutasteride in 2001. In 1992, finasteride (5 mg) was approved by the US Food and Drug Administration (FDA) for treatment of BPH, which Merck marketed under the brand name Proscar. He was intrigued by the notion that decreased levels of DHT led to the development of smaller prostates. Upon maturation, these individuals were observed to have smaller prostates which were underdeveloped, and were also observed to lack incidence of male pattern baldness. She reported on a group of intersex children in the Caribbean who appeared sexually ambiguous at birth, and were initially raised as girls, but then grew external male genitalia and other masculine characteristic after onset of puberty. The study recruited hypogonadal males between 18 and 60 years old who required T replacement therapy. The T plus D and D alone groups but not the T only group received a D loading dose of 24.5 mg, followed by 3 consecutive days of 0.25 mg D BID before starting the 28-day treatment phase. Subjects were randomized using a random number sequence to 1 of 5 treatments administered orally BID, including 1) 150 mg T plus 0.25 mg D, 2) 250 mg T plus 0.25 mg D, 3) 400 mg T plus 0.25 mg D, 4) 400 mg T alone or 5) 0.25 mg D alone. This randomized, open label, parallel group study consisted of a screening period, followed by a continuous 28-day treatment period (fig. 1). Current approved T therapies in the United States include injections, patches, gels, buccal tablets and oral alkylated T derivatives, eg methyltestosterone and oxandrolone. This is why some very hair loss prone individuals who truly value their hair more than their masculinity are using oral anti-androgens now in the hair loss community. Hence why most guys can use Dutasteride with no side effects, and those that experience androgen deficient side effects simply have free-[buy testosterone cypionate](https://employ.co.il/employer/the-molecular-mechanism-of-sex-hormones-on-sertoli-cell-development-and-proliferation/) levels that are too low to fulfill that androgen deficit, or do not understand effective Estrogen/general hormone management. Lowering androgenic activity in the body is totally counterproductive to being a male, and presents the paradox men face with their endocrine system. The intention of the drug was not to address hair loss, the creators simply realized that a fringe benefit of inhibiting prostate growth by systemically inhibiting DHT conversion is that your hair can grow back because there's less androgen induced miniaturization occurring. Even once I accomplished DHT inhibition, I had continuous androgenic side effects just from [buy testosterone injections](https://git.automathon.org/chassidydurand). The side effects would predictably be mitigated with exogenous androgen administration, or Estrogen management in almost all cases, dependent on what the root of the issue was specifically. That's great because it fulfills the androgenic properties that would otherwise be fulfilled by DHT. The less favorable the myotrophic-to-androgenic ratio is of a drug, the less ideal of a hormone replacement therapy option it is for men seeking to minimize androgenic alopecia. I still experienced body hair growth, and despite it somewhat notably being reduced on my lower back area, I still had to manscape once a week to keep my body hair growth under control in general. All youre doing with Finasteride is putting your ticking time bomb of hair loss in slow motion. Androgenic alopecia never let up until I addressed androgens, and to be clear, for 90-99% of men, the same will apply. I've been on 500 milligrams of Test with Dianabol in the past (among other heavily aromatizing compounds) and had absurdly out of range Estrogen levels because I was young, stupid and wasn't using an aromatase inhibitor (AI) to manage my hormones correctly. I've kept in the middle just by not using those androgens, and manually managed it at other times when I was using those drugs. Finasteride and other antiandrogens might be useful in the treatment of obsessivecompulsive disorder (OCD), but more research is needed. Two case series have reported that finasteride is effective in the treatment of hidradenitis suppurativa in girls and women. DHT may be involved in the cause of acne, and 5α-reductase inhibitors might be effective in the treatment of the condition. Changes in prostate volume and PSA level were not significantly related to either [buy testosterone injections](http://41.180.4.117:3000/celindatrost4) dose or concentration, and did not differ significantly between the placebo and dutasteride groups (eFigure 2). There was no significant interaction between [buy testosterone cypionate](https://www.quranpak.site/vedabean282931) dose and randomization to dutasteride or placebo, indicating a lack of evidence that the relationship of [testosterone online pharmacy](https://git.vezpi.com/solomonj000896) dose to change in fat-free mass differed between the dutasteride and placebo groups. Fat-free mass and lean body mass increased in a dose-dependent manner in the placebo and dutasteride groups (FIGURE 2).